We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to the rejection of Lumacaftor (Polymorph) […]
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to the rejection of Lumacaftor (Polymorph) […]
After successfully conducting several symposiums in 2016, IIPRD is coming up with a one-day seminar on software and electronics patent portfolio with a focus on preliminary preparation, prosecution, […]
After successfully conducting several symposiums in 2016, IIPRD is coming up with a one-day seminar on software and electronics patent portfolio with a focus on preliminary preparation, prosecution, […]